175 related articles for article (PubMed ID: 27520732)
1. Counter-ion complexes for enhanced drug loading in nanocarriers: Proof-of-concept and beyond.
Günday Türeli N; Türeli AE; Schneider M
Int J Pharm; 2016 Sep; 511(2):994-1001. PubMed ID: 27520732
[TBL] [Abstract][Full Text] [Related]
2. Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections.
Günday Türeli N; Torge A; Juntke J; Schwarz BC; Schneider-Daum N; Türeli AE; Lehr CM; Schneider M
Eur J Pharm Biopharm; 2017 Aug; 117():363-371. PubMed ID: 28476373
[TBL] [Abstract][Full Text] [Related]
3. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
Khan AM; Ahmad FJ; Panda AK; Talegaonkar S
Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254
[TBL] [Abstract][Full Text] [Related]
4. Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach.
Günday Türeli N; Türeli AE; Schneider M
Int J Pharm; 2016 Dec; 515(1-2):343-351. PubMed ID: 27744035
[TBL] [Abstract][Full Text] [Related]
5. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobic ion pairing of a minocycline/Ca(2+)/AOT complex for preparation of drug-loaded PLGA nanoparticles with improved sustained release.
Holmkvist AD; Friberg A; Nilsson UJ; Schouenborg J
Int J Pharm; 2016 Feb; 499(1-2):351-357. PubMed ID: 26773599
[TBL] [Abstract][Full Text] [Related]
7. Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential.
Khuroo T; Verma D; Talegaonkar S; Padhi S; Panda AK; Iqbal Z
Int J Pharm; 2014 Oct; 473(1-2):384-94. PubMed ID: 25051112
[TBL] [Abstract][Full Text] [Related]
8. In situ gel-forming AP-57 peptide delivery system for cutaneous wound healing.
Li X; Fan R; Tong A; Yang M; Deng J; Zhou L; Zhang X; Guo G
Int J Pharm; 2015 Nov; 495(1):560-571. PubMed ID: 26363112
[TBL] [Abstract][Full Text] [Related]
9. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
[TBL] [Abstract][Full Text] [Related]
10. PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions.
Cavallaro G; Craparo EF; Sardo C; Lamberti G; Barba AA; Dalmoro A
Int J Pharm; 2015 Nov; 495(2):719-27. PubMed ID: 26410757
[TBL] [Abstract][Full Text] [Related]
11. Co-encapsulation of lyoprotectants improves the stability of protein-loaded PLGA nanoparticles upon lyophilization.
Fonte P; Araújo F; Seabra V; Reis S; van de Weert M; Sarmento B
Int J Pharm; 2015 Dec; 496(2):850-62. PubMed ID: 26474964
[TBL] [Abstract][Full Text] [Related]
12. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
13. Formulation and comparative in vitro evaluation of various dexamethasone-loaded pH-sensitive polymeric nanoparticles intended for dermal applications.
Sahle FF; Gerecke C; Kleuser B; Bodmeier R
Int J Pharm; 2017 Jan; 516(1-2):21-31. PubMed ID: 27845215
[TBL] [Abstract][Full Text] [Related]
14. Core-shell structured gel-nanocarriers for sustained drug release and enhanced antitumor effect.
He W; Lv Y; Zhao Y; Xu C; Jin Z; Qin C; Yin L
Int J Pharm; 2015 Apr; 484(1-2):163-71. PubMed ID: 25724136
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable nanoparticles from prosopisylated cellulose as a platform for enhanced oral bioavailability of poorly water-soluble drugs.
Kenechukwu FC; Dias ML; Ricci-Júnior E
Carbohydr Polym; 2021 Mar; 256():117492. PubMed ID: 33483021
[TBL] [Abstract][Full Text] [Related]
16. Elaboration and characterization of curcumin-loaded soy soluble polysaccharide (SSPS)-based nanocarriers mediated by antimicrobial peptide nisin.
Luo L; Wu Y; Liu C; Zou Y; Huang L; Liang Y; Ren J; Liu Y; Lin Q
Food Chem; 2021 Jan; 336():127669. PubMed ID: 32758804
[TBL] [Abstract][Full Text] [Related]
17. Denatured protein-coated docetaxel nanoparticles: Alterable drug state and cytosolic delivery.
Zhang L; Xiao Q; Wang Y; Zhang C; He W; Yin L
Int J Pharm; 2017 May; 523(1):1-14. PubMed ID: 28323094
[TBL] [Abstract][Full Text] [Related]
18. Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles.
Fonte P; Lino PR; Seabra V; Almeida AJ; Reis S; Sarmento B
Int J Pharm; 2016 Apr; 503(1-2):163-73. PubMed ID: 26972381
[TBL] [Abstract][Full Text] [Related]
19. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
[TBL] [Abstract][Full Text] [Related]
20. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
